Capital Market

The Lexelians team has a recognized expertise in Capital Markets. The team is composed of Laurent Beauvoit, Jonathan Santoro and Ophélie Charles. We advise listed companies in the following transactions:

IPOs and listings (Euronext, Growth, Access)
Public offers and private placements
Capital increases and issues of securities (equity line, bonds, warrants, convertible bonds, OCEANE, ORNANE …)
Tenders offers, exemption to tender offers
Mergers, scissions, contributions in kinds
Debt restructurings & Off-market block trades

Laurent Beauvoit and its team have been involved in more than two hundreds financial transactions including IPOs/privatizations (EDF, ConcoursMania, Diaxonhit, Horizontal Software, Predilife ...), capital increases (Société Générale, France Telecom, Veolia Environnement, Rhodia, Diaxonhit ...), issues of securities (convertibles, ORNANEs, OCEANEs … by Business Objects, Altran, Publicis ...), tender offers (Grand Marnier, Business Objects, Infogrames ...) and bond issues (Aurea, Infogrames, Rhodia, CMA-CGM ...).

Lexelians is regularly ranked in specialized magazines. Lexelians was ranked in the "Excellent" category of the "Capital Markets - Smid Cap" firms by the magazine « Décideurs Stratégie Finance Droit ». The Legal 500 Paris recommends Laurent Beauvoit for the quality of its support for companies listed on Euronext Growth.

Our latest transactions

IPOs and Listings

Media Maker

Listing by private placement on Euronext Access Paris (€2.5 M).

July 2019 - Corporate and financial counsel of the company.

Predilife

IPO on Euronext Growth (€2.6 M).

December 2018 - Deal counsel

Parx Plastics

Listing by private placement on Euronext Access Paris.

May 2018 - Corporate and financial counsel of the company.

Medialab

Listing by private placement on Euronext Access Paris.

March 2018 - Corporate and financial counsel of the company.

Gour Medical

Listing by private placement on Euronext Access Paris.

December 2016 - Corporate and financial counsel of the company.

Horizontal Software

IPO on Euronext Growth Paris (€6 M).

December 2016 - Deal counsel

Orclass

Listing by private placement on Euronext Access Paris.

December 2016 - Corporate counsel of the company.

Groupe Concourmania

IPO on Euronext Growth Paris (€9.2 M).

May 2011 - Deal counsel
Capital increases (Public Offering and private placement)

Gour Medical

Private placement.

September 2019 - Corporate and financial counsel of the company.

Théraclion

Issuance by private and convertible bonds (€4.8 M).

March 2019 - Corporate and financial counsel of the company.

Eurobio Scientific

Issuance of shares by private placement (€3 M).

March 2019 - Corporate and financial counsel of the company.

Eduniversal

Private placement.

March 2019 - Corporate and financial counsel of the company.

Horizontal Software

Capital increase by private placement.

March 2019 - Corporate and financial counsel of the company.

Gour Medical

Private placement.

February 2019 - Corporate and financial counsel of the company.

Horizontal Software

Capital increase by private placement (€1.3 M).

February 2018 - Corporate and financial counsel of the company.

Théraclion

Issuance of shares by private placement (€4.2 M).

October 2017 - Corporate and financial counsel of the company.

Eurobio Scientific

Public offering of shares (€28.9 M).

February 2017 - Corporate and financial counsel of the company.

Théraclion

Capital increase with preferential subscription rights (€10 M).

August 2016 - Corporate and financial counsel of the company.

Théraclion

Issuance of shares by private placement (€1.8 M).

May 2016 - Corporate and financial counsel of the company.

Eurobio Scientific

Capital increase reserved to a category of beneficiaries ("TEPA" law).

November 2015 - Corporate and financial counsel of the company.

Théraclion

Inssuancve of shares by private placement (€4 M).

June 2015 - Corporate and financial counsel of the company.

Eurobio Scientific

Capital increase reserved to a category of beneficiaries ("TEPA" law).

March 2015 - Corporate and financial counsel of the company.

Eurobio Scientific

Capital increase reserved to a category of beneficiaries ("TEPA" law).

May 2014 - Corporate and financial counsel of the company.
Issues of Securities, Equity Lines, bonds issues

Novacyt Group

Equity line (€5 M).

April 2019 - Counsel of the investor.

Théraclion

Issuance by private placement and convertible bonds (€4.8 M).

March 2019 - Corporate and financial counsel of the company.

GECI International

Issuance of convertible bonds (ORNANE) (€4 M).

February 2019 - Corporate and financial counsel of the company.

Horizontal Software

Issuance of convertible bonds (OCEANE) with share purchase warrants (€2 M).

July 2018 - Corporate and financial counsel of the company.

Aurea

Issuance of bonds (€5 M).

June 2018 - Corporate and financial counsel of the company.

Théraclion

Equity line (€3.6 M).

July 2018 - Corporate and financial counsel of the company.

Vergnet Groupe

Equity line (2 tranches of €2 M).

May 2018 - Corporate and financial counsel of the company.

Sepimo

Issuance of convertible bonds (€5 M).

February 2018 - Corporate counsel of the company.

GECI International

Issuance of convertible bonds (ORNANE) (€9 M).

July 2017 - Corporate and financial counsel of the company.

SCBSM

Issuance of converible bonds (ORNANE) (€20 M).

May 2017 - Corporate and financial counsel of the company.

Théraclion

Equity line (€3 M).

March 2015 - Corporate and financial counsel of the company.

Eurobio Scientific

Issuance of convertible bonds (OCABSA) (€10 M).

June 2014 - Corporate and financial counsel of the company.

Aurea

Issuance of bonds (€13.6 M).

June 2013 - Corporate and financial counsel of the company.
Tender Offers, exemption requests

Aurea

Share buyback public offer (€15 M).

October 2019 - Deal counsel.

Grand Marnier

Takeover offer launched by Campari (€680 M).

May 2016 - Financial counsel of Grand Marnier.
Mergers, demergers, contributions in kinds

Horizontal Software

Universal transfer of assets of Tehems, LPDR, Formaeva and Equitime.

June 2019 - Corporate counsel of the group.

Eurobio Scientific

Contributions is kind for the acquisition of Pathway Diagnostics (€1 M).

June 2019 - Corporate and financial counsel of the group.

Eurobio Scientific

Universal transfer of the assets of Eurobio.

December 2018 - Corporate and financial counsel of the group.

Horizontal Software

Contributions is kind for the acquisition of Formaeva

December 2017 - Corporate and financial counsel of the group.

Eurobio Scientific

Universal transfer of assets of Eurobio and Ingen.

December 2017 - Corporate counsel of the group.

Eurobio Scientific

Contributions in kind for the acquisition of Capforce Plus (€18.8 M).

Mars 2017 - Corporate and financial counsel of the group.

Eurobio Scientific

Universal transfer of assets of Ingen Biosciences and Ingen.

December 2013 - Corporate counsel of the group.

Eurobio Scientific

Contributions in kind for the acquisition of Ingen Biosciences (€10 M).

December 2012 - Corporate and financial counsel of the group.